<DOC>
	<DOCNO>NCT01686061</DOCNO>
	<brief_summary>The purpose survey collect detailed information patient treat blepharospasm incobotulinumtoxinA , abobotulinumtoxinA onabotulinumtoxinA , include often treat botulinum toxin , long treatment last , satisfy treatment , improvement symptom treatment .</brief_summary>
	<brief_title>Blepharospasm Patient Survey Patients With Blepharospasm</brief_title>
	<detailed_description>This study open male female &gt; 18 year &lt; 81 year clinical diagnosis blepharospasm .</detailed_description>
	<mesh_term>Blepharospasm</mesh_term>
	<criteria>Male female subject age &gt; 18 year &lt; 81 year Documented clinical diagnosis blepharospasm Currently receive incobotulinumtoxinA , abobotulinumtoxinA onabotulinumtoxinA Previous treatment rimabotulinumtoxinB last 2 treatment cycle</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>